| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 05/24/2006 | CN1775806A 2, 4, 6-trichlorophen artificial antigen, and its preparing method and use |
| 05/24/2006 | CN1775805A 2, 4-dichlorophen artificial antigen, and its preparing method and use |
| 05/24/2006 | CN1775804A UreG protein, and its preparing method and sue |
| 05/24/2006 | CN1775803A Plant DREB transcription factor and its coding gene and use |
| 05/24/2006 | CN1775802A Human papillomavirus immunogenic polypeptide, and its preparing method and use |
| 05/24/2006 | CN1775801A Low molecular weight peptide derivatives as inhibitors of the laminin/nidogen interaction |
| 05/24/2006 | CN1775800A Recombinant protein efficient renaturation method |
| 05/24/2006 | CN1775797A Boea clarkeane drought-resistant and salt-tolerance related gene and its coding protein and use |
| 05/24/2006 | CN1775285A Use of glucoprotein for pharmaceuticals |
| 05/24/2006 | CN1257286C Targeted adenovirus vectors for delivery of heterologous genes |
| 05/24/2006 | CN1257186C Interferon gamma polypeptide variants |
| 05/24/2006 | CN1257185C Process for preparing coagulants for water treatment |
| 05/24/2006 | CN1256890C Method for preparation of gliadin and glutenin rich fractions out of gluten in aqueous medium and in presence of acid |
| 05/23/2006 | US7049491 Expression vector comprising DNA sequences coding modified insecticidal protein (CRY1AB) for biological pest control |
| 05/23/2006 | US7049489 Transgenic plant; transformation plant with nucleic acids; gene expression; shutter vectors; genetic engineering |
| 05/23/2006 | US7049488 Nucleic acids that control seed and fruit development in plants |
| 05/23/2006 | US7049480 Methods of enucleating an avian oocyte or zygote using two-photon laser scanning microscopy |
| 05/23/2006 | US7049425 Methods and compositions utilizing an alternative splice variant of the sigma-1 receptor |
| 05/23/2006 | US7049424 Genes from the 20Q13 amplicon and their uses |
| 05/23/2006 | US7049423 Nucleic acids coding fuion protein; gene expression |
| 05/23/2006 | US7049422 Tumor necrosis related receptor, TR7 |
| 05/23/2006 | US7049419 Pneumococcal surface protein C (PspC), epitopic regions and strain selection thereof, and uses therefor |
| 05/23/2006 | US7049418 Nucleotide sequences coding polypeptides for use in the treatment and prevention of infections |
| 05/23/2006 | US7049416 Phosophoinositoglycan binding proteins |
| 05/23/2006 | US7049415 Pegylated T20 polypeptide |
| 05/23/2006 | US7049414 Complex of lecithin and sugar; immobilization; washing; liquid removal; recovering |
| 05/23/2006 | US7049413 MAGE-A3 peptides presented by HLA class II molecules |
| 05/23/2006 | US7049410 Antibody for use in the detection of tumors |
| 05/23/2006 | US7049409 Heregulin-like factor antibodies |
| 05/23/2006 | US7049406 Amplified genetic expression of genetically engineered hemoglobin; obtain cell, transform with vector coding genetically engineered hemoglobin, express vector, recover hemoglobin |
| 05/23/2006 | US7049404 Polypeptide human polyadenylation binding protein 20.13 and polynucleotide encoding it |
| 05/23/2006 | US7049403 Insulin/IGF/relaxin family polypeptides and DNAS thereof |
| 05/23/2006 | US7049402 Tumor necrosis factor receptor-5 |
| 05/23/2006 | US7049401 Geneteic engineered protein; isolation, purification; cloning Dna; central nervous system disorders |
| 05/23/2006 | US7049399 Making glatiramer acetate; polymerization of the N-carboxyanhydrides of L-alanine, tyrosine, gamma -benzyl glutamate and N epsilon-benzyloxycarbonyl lysine to make a protected copolymer, and deprotecting, separation and purification, in various solvents |
| 05/23/2006 | US7049295 Compounds and use thereof to modify transport across cell membranes |
| 05/23/2006 | US7049293 Peptide and osteogenetic accelerator |
| 05/23/2006 | US7049292 Administering a peptide having a sequence of QPLALEGSLQK in combination with another polypeptide to treat insulin dependent diabetes mellitus (IDDM or Type 1 diabetes) |
| 05/23/2006 | US7049291 For therapy of cartilage, bone, nerve or muscle growth disorder in a mammal |
| 05/23/2006 | US7049290 Essential downstream component of the wingless signaling pathway and therapeutic and diagnostic applications based thereon |
| 05/23/2006 | US7049289 Labelled glutamine and lysine analogues |
| 05/23/2006 | US7049287 Nociceptin-based analgesics |
| 05/23/2006 | US7049286 Insulin conjugates and methods of use thereof |
| 05/23/2006 | US7049285 Spacers provide regions of hydrophobicity and positive charge and enhance their interaction with cell membrane to increase the cell trafficking, endosomal disruption, the circulation half-life in blood, and stability |
| 05/23/2006 | US7049284 For therapy of medical conditions resulting from the impaired growth or loss of gastrointestinal tissue, particularly intestinal and pancreatic tissue |
| 05/23/2006 | US7049138 Nucleotide sequences coding polypeptide for use in the treatment of nervous system disorders |
| 05/23/2006 | US7049137 KCNQ5, a novel potassium channel |
| 05/23/2006 | US7049136 Redirection of cellular immunity by receptor chimeras |
| 05/23/2006 | US7049134 Contains a rep gene open reading frame from a geminiviridae, circoviridae or genus nanovirus |
| 05/23/2006 | US7049133 Nucleotide sequences for use in regulation of transcription in eukaryotes |
| 05/23/2006 | US7049132 retroviral expression vector, G1NaGRPTK; controlled release and liposomal formulations; freeze dried and unit dosage forms; gene therapy; anticarcinogenic and antidiabetic agents; side effect reduction; genetic engineering of transgenic animals |
| 05/23/2006 | US7049131 Methods and deoxyribonucleic acid for the preparation of tissue factor protein |
| 05/23/2006 | US7049128 For therapy of vascular inflammation and other vascular disorders associated with platelet activation |
| 05/23/2006 | US7049120 Regulation of human mrp5-like protein |
| 05/23/2006 | US7049113 to the luciferin-luciferase reaction system; culturing a host cell, isolation of the protein; genetic engineering; improved durability of luminescence |
| 05/23/2006 | US7049112 Comprise CPRA protein (cytochrome enzyme complexes) for bioynthesis of long chain aliphatic dioic acids |
| 05/23/2006 | US7049111 hydroxymethylglutaryl coenzyme A reductase; isolated DNA; recombinant DNA vector; transformed cell; culturing the transformed cell to produce a hydroxylase; hydroxylation, separation; anticholesterol agents |
| 05/23/2006 | US7049108 Processes for producing lactic acid using yeast transformed with a gene encoding lactate dehydrogenase |
| 05/23/2006 | US7049099 Recombinant human mannan-binding proteins and producing method of the same |
| 05/23/2006 | US7049096 Polynucleotides encoding a novel human G-protein coupled receptor splice variant HGPRBMY29sv1 |
| 05/23/2006 | US7049095 DNA encoding IL-1 receptor accessory protein |
| 05/23/2006 | US7049094 Detection of modulator of transport protein activity; obtain sample containing transport protein, incubate with potential modulator, monitor binding activity, reduction in binding indicates effective modulator |
| 05/23/2006 | US7049090 Modulation of hedgehog-mediated signaling pathway |
| 05/23/2006 | US7049081 Antiproliferative gene |
| 05/23/2006 | US7049071 Nucletide sequences coding protein for use as diagnostic tool in the detection of genetic damage |
| 05/23/2006 | US7049066 Diagnosis and treatment of myocardial failure |
| 05/23/2006 | US7049063 Lung tumor polypeptides, immunogenic portions thereof, polynucleotides that encode such polypeptides, antigen presenting cell that expresses such polypeptides, and T cells that are specific for cells expressing such polypeptides. |
| 05/23/2006 | US7048949 with target membrane or other hydrophobic proteins (G protein coupled receptor protein) or membrane fragments to form soluble nanoscale particles which preserve their native structure and function; allows manipulation of incorporated proteins in solution or on solid supports |
| 05/23/2006 | US7048932 Preparation and standardization of immunomodulatory peptide-linked glucans with verifiable oral absorbability from coriolus versicolor |
| 05/23/2006 | US7048930 Expression of core-glycosylated HCV envelope proteins in yeast |
| 05/23/2006 | US7048929 approximates conformational discontinuous epitopes of a primate lentivirus envelope protein, modifications of the structure has enhanced stability, raises a greater range of antibodies to conserved epitopes, and/or has enhanced immunogenicity for broadly neutralizing epitopes. |
| 05/23/2006 | US7048922 Protocol of activating and administering human blood cells so that bone marrow histology and/or blood cell counts of patients suffering from aplastic anemia approach normal. The protocol includes culturing the blood cells in the presence of |
| 05/23/2006 | US7048211 Flexible processing apparatus for isolating and purifying viruses, soluble proteins and peptides from plant sources |
| 05/23/2006 | CA2335305C A bioluminescence resonance energy transfer (bret) system and its use |
| 05/23/2006 | CA2322371C Antimicrobial agent against acid resistant and heat-resistant bacteria |
| 05/23/2006 | CA2259550C Cosmetic or dermatological compound containing at least one natural, recombinant or analogous arachnid silk protein |
| 05/23/2006 | CA2173747C Calcium receptor-active arylalkyl amines |
| 05/23/2006 | CA2075206C Production of recombinant polypeptides by bovine species and transgenic methods |
| 05/18/2006 | WO2006053299A2 Site-directed modification of fviii |
| 05/18/2006 | WO2006053015A2 Composition and method for increasing apoptosis in cancer cells |
| 05/18/2006 | WO2006052534A2 Expansion of nk cells and therapeutic uses thereof |
| 05/18/2006 | WO2006052493A1 Polypeptides that bind baff and/or april |
| 05/18/2006 | WO2006052468A2 Adrenocorticotropic hormone analogs and related methods |
| 05/18/2006 | WO2006052363A2 Co-expression of multiple protein chains or subunits |
| 05/18/2006 | WO2006052031A1 Protein hydrolysate with antidiabetic effect |
| 05/18/2006 | WO2006052003A1 Soluble polypeptide derived from pea whey, foaming agent and process for producing the same |
| 05/18/2006 | WO2006051946A1 Novel polypeptide having protease inhibitory activity |
| 05/18/2006 | WO2006051944A1 Fluorescent protein |
| 05/18/2006 | WO2006051805A1 MUTANT INTERFERON α PROTEINS AND USE THEREOF |
| 05/18/2006 | WO2006051545A2 Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis |
| 05/18/2006 | WO2006051418A2 Transcription factor of the zn binuclear cluster family of fungal regulators |
| 05/18/2006 | WO2006051396A1 Mutant porcine reproductive and respiratory syndrome virus |
| 05/18/2006 | WO2006051387A1 Method of producing a carnitine-synthesising micro-organism |
| 05/18/2006 | WO2006051333A2 Leucine-rich repeat (lrr) motif containing proteins |
| 05/18/2006 | WO2006051313A2 Peptides designed to switch folded state upon binding metals |
| 05/18/2006 | WO2006051070A1 Method for purifying fsh |
| 05/18/2006 | WO2006050977A1 Recombinant trl-md-2 fusion proteins |
| 05/18/2006 | WO2006050945A2 Tubulin mutation diagnostic |
| 05/18/2006 | WO2006050737A1 Polypeptides having antimicrobial activity and polynucleotides encoding same |
| 05/18/2006 | WO2006050571A1 Chlamydia antigens and uses thereof |